Page 17 - Omnipod System News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Omnipod system. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Omnipod System Today - Breaking & Trending Today

James Hollingshead Buys 5,550 Shares of Insulet Co. (NASDAQ:PODD) Stock

Insulet Co. (NASDAQ:PODD – Get Free Report) CEO James Hollingshead bought 5,550 shares of the business’s stock in a transaction that occurred on Monday, August 28th. The shares were acquired at an average price of $181.41 per share, for a total transaction of $1,006,825.50. Following the completion of the transaction, the chief executive officer now […] ....

United States , New York , James Hollingshead , Lindbrook Capital , Morgan Stanley , Jpmorgan Chase Co , American National Bank , Quintet Private Bank Europe , First Manhattan Co , Heritage Wealth Management , Insulet Corporation , Wells Fargo Company , Securities Exchange Commission , Insulet Co , Get Free Report , Exchange Commission , National Bank , Wealth Management , Omnipod System , Insulet Daily , Nasdaq Podd , Insider Trading , Nsider Trades ,

Insulet (NASDAQ:PODD) PT Lowered to $208.00

Insulet (NASDAQ:PODD – Free Report) had its target price cut by Morgan Stanley from $343.00 to $208.00 in a report published on Thursday morning, MarketBeat Ratings reports. They currently have an equal weight rating on the medical instruments supplier’s stock. Other analysts have also issued research reports about the company. StockNews.com started coverage on Insulet […] ....

New York , United States , Piper Sandler , Shacey Petrovic , Wayded Mcmillan , Lindbrook Capital , Morgan Stanley , Insulet Corporation , Insulet Company Profile , Wells Fargo Company , American National Bank , Quintet Private Bank Europe , First Manhattan Co , Securities Exchange Commission , Heritage Wealth Management , Free Report , Marketbeat Ratings , Moderate Buy , Stock Down , Get Free Report , Exchange Commission , Director Shacey Petrovic , National Bank , Wealth Management , Omnipod System , Insulet Daily ,

Bank of America Trims Insulet (NASDAQ:PODD) Target Price to $295.00

Insulet (NASDAQ:PODD – Free Report) had its price target cut by Bank of America from $365.00 to $295.00 in a research report report published on Thursday, MarketBeat.com reports. They currently have a buy rating on the medical instruments supplier’s stock. Other equities research analysts also recently issued reports about the stock. Raymond James reduced their […] ....

United States , Dan Manea , Raymond James , Shacey Petrovic , Insulet Corporation , Blueshift Asset Management , Wells Fargo Company , National Pension Service , Moneta Group Investment Advisors , Tennessee Treasury Department , Securities Exchange Commission , Free Report , Moderate Buy , Trading Down , Get Free Report , Director Shacey Petrovic , Exchange Commission , Retirement System , Pension Service , Asset Management , Group Investment Advisors , Omnipod System , Insulet Daily , Nasdaq Podd , Lower Price Target , Bank Of America Co ,

Bessemer Group Inc. Has $101,000 Stock Holdings in Insulet Co. (NASDAQ:PODD)

Bessemer Group Inc. boosted its holdings in shares of Insulet Co. (NASDAQ:PODD – Free Report) by 37.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 315 shares of the medical instruments supplier’s stock after purchasing an additional 85 shares during […] ....

United States , Raymond James , Banque Cantonale Vaudoise , Wayded Mcmillan , Piper Sandler , Dan Manea , Keybank National Association , Lincoln National Corp , Insulet Co , Morgan Stanley , Bessemer Group Inc , Global Retirement Partners , Insulet Corporation , Securities Exchange Commission , Synovus Financial Corp , Bessemer Group , Free Report , Financial Corp , National Corp , National Association , Cantonale Vaudoise , Retirement Partners , Exchange Commission , Trading Down , Omnipod System , Insulet Daily ,

Insulet (NASDAQ:PODD) Upgraded to Buy at Citigroup

Citigroup upgraded shares of Insulet (NASDAQ:PODD – Free Report) from a neutral rating to a buy rating in a report released on Monday, Marketbeat Ratings reports. They currently have $265.00 price target on the medical instruments supplier’s stock, down from their previous price target of $273.00. A number of other brokerages also recently commented on […] ....

Piper Sandler , Robertw Baird , Dan Manea , Wayded Mcmillan , Wells Fargo Company , Insulet Corporation , Securities Exchange Commission , Raymond James Financial Services Advisors Inc , Dimensional Fund Advisors , Vontobel Holding Ltd , Insulet Company Profile , Metlife Investment Management , Synovus Financial Corp , Free Report , Marketbeat Ratings , Moderate Buy , Trading Down , Exchange Commission , James Financial Services Advisors , Life Investment Management , Financial Corp , Fund Advisors , Vontobel Holding , Get Free Report , Omnipod System , Insulet Daily ,